Toronto-based Analytics 4 Life just raised $25 million in Series B financing to develop and ultimately commercialize their non-invasive cardiovascular diagnostic. The device, called CorVista, reads ...

Cardiac magnetic resonance imaging (MRI) is an appropriate non-invasive procedure for functional diagnostics in patients who, ...

Dramatic reductions in analysis time are possible with the new generation of artificial intelligence diagnostic interpretative systems for echocardiography that are transforming innovative approaches ...

Since its launch in 2007, Boston Heart Diagnostics has been transforming the treatment of cardiovascular disease by arming health care providers with diagnostics designed to give a more detailed look ...

DUBLIN--(BUSINESS WIRE)--The "Global Cardiac Biomarker Diagnostic Kits Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ...

Heart failure, in the simplest of terms, indicates that a problem with the ventricles is preventing the heart from filling and/or pumping correctly. It is the result of a complex mechanical and ...

Cardiac diagnostics firm Critical Care Diagnostics Inc. has landed some new capital as it works with clinical laboratories to make its cardiac biomarker assay, ST2, available to physicians. The ...

BOSTON--(BUSINESS WIRE)--AISAP, a medical technology company developing AI-powered Point-of-Care Assisted Diagnosis (POCAD™) solutions to transform medical ultrasound, has partnered with Miami-based ...

Dallas, TX, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and strategy firm, has released its latest PatentVest Pulse report, “The State of Cardiac ...

Luxembourg-based Eurofins Scientific ($EUFI) agreed to buy Boston Heart Diagnostics, an advanced diagnostics provider, for $140 million, the company said. The deal ...